Related Experiment Video
Updated: Jun 4, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Food and Drug Administration Expert Panel on Infant Formula "Operation Stork Speed" June 2025: Part 1, Nutrient
Steven A Abrams1, J Thomas Brenna1, Roger Clemens2
1Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States.
Abstract:
Operation Stork Speed, launched by the Food and Drug Administration in March 2025, represents a comprehensive initiative to update infant formula regulations that have remained largely unchanged since the 1980s. This expert panel review addresses recommendations for nutrients considering 4 decades of accumulated scientific evidence. Current Food and Drug Administration fatty acid regulations specify only total fat content and minimum linoleic acid requirements, despite substantial international consensus on polyunsaturated fatty acid specifications. Evidence strongly supports establishing maximum linoleic acid concentrations and docosahexaenoic acid and arachidonic acid requirements, reflecting the critical role of omega-3 (ω-3) fatty acids in neurocognitive development and visual acuity. The panel emphasizes that saturated and monounsaturated fatty acids comprise over 80% of human milk fatty acids, while acknowledging recent concerns about seed oils and supporting balanced PUFA formulations. Carbohydrate composition presents significant concerns, as over half of United States formulas contain glucose polymers (e.g., corn syrup solids) despite lactose being the primary carbohydrate energy source in human milk. Observational studies have linked corn syrup-based formulas to multiple potential health risks, including excess weight gain, warranting reconsideration of the value of non-lactose carbohydrate substitutions in formulas for healthy children. Protein content recommendations support decreasing the upper range of allowable intake, aligning with European standards and addressing concerns about excessive protein intake contributing to later obesity risk. Micronutrient evaluation reveals the need to reduce the iron content in routine formulas, consistent with European Food Safety Authority recommendations and emerging safety data, and a need to set upper limits for the concentration of calcium and phosphorus. Overall, infant formula is a healthy product that has been successfully feeding infants for many decades. These comprehensive updates aim to more closely align United States infant formula regulations with current scientific understanding and international standards while supporting optimal infant growth, development, and long-term health outcomes.
Related Concept Videos
Factors Affecting Drug Response: Overview
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Bioavailability: Influencing Factors
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution

